A check of the FDA's public device databases, 510(k) and PMA, for the product name "REJURAN" turns up no approval record. At UH CELL's Gangnam branch, interpreting staff who can assist in Japanese, Chinese and English work at the clinic. The Rejuran procedure we offer there is an injection placed into the skin. It isn't a cosmetic product.

What the FDA Database Search Shows and Does Not Show
510(k) and PMA are the two databases the FDA uses to publish its medical device clearance and approval records. A search of both, run on November 10, 2026, for the product name "Rejuran" returned no matching entries. That result says one thing: as of that search date, these two databases carry no record of an approval for an injectable product under the name Rejuran. The search doesn't rule out the possibility that the same material sits under a different product name. It isn't proof that the FDA reviewed the product's safety and rejected it, either. Not finding an approval record and the FDA judging a product unsafe are two different things. This search showed the absence of a record. It didn't show a safety verdict. Database listings can change between searches. Anyone comparing a planned procedure against this finding can rerun the same search later, using the exact product name printed on their own treatment plan.
The distinction has into how marketing language gets read. Some product descriptions use the phrase "FDA registered," and that phrase doesn't carry the same meaning as "FDA approved." The FDA's own guidance on registration and listing states that establishment registration and device listing don't amount to product approval or clearance. The guidance also states that the agency doesn't issue certificates of registration and doesn't certify listed devices. So a product described as "FDA registered" hasn't necessarily gone through the approval or clearance process that the word "approved" describes.
Cosmetics Sold in the US, an Injectable Sold in Korea
Rejuran's US website leads to a cosmetics line: ampoules, creams and masks meant to be applied to the surface of the skin. That line being sold in the US has no bearing on whether the injectable version used in Korean clinics has FDA clearance. Efficacy language printed on a cosmetic bottle doesn't carry over to the result of an injection placed under the skin, either. Ingredient labels on both product types can look alike: PN, PDRN and c-PDRN appear on each. The product's identity and its intended route, injected or applied, are listed separately on each item.
The injectable product's identity comes from the manufacturer's official instruction leaflet, published in its April 2025 edition. That document lists approval number 제허14-825호, covering three product names: Rejuran, Rejuran I, and Rejuran S. It classifies the product as a tissue-repair biomaterial. Its stated purpose is the temporary improvement of facial wrinkles in adults. As a PN-based injectable device, it sits in a different product category from a topical cosmetic from the start. Rejuran HB+ doesn't appear on that document's list of product names. It's a separate product, so the approval number and instructions above cover a different product name and a different use. Its own labeling needs a separate look.
What to Check on the Packaging Before a Procedure
The difference between an injectable and a cosmetic shows up mostly on the box and the label. Before a procedure, these points can be compared against what's printed on the package and the instruction leaflet:
- Compare the product name on the box with the name listed in the instruction leaflet.
- Confirm whether the formulation is meant for injection or for topical use.
- Look for the approval number and the country that issued it, printed on the package.
Going through these points one at a time cuts down on mixing up different products sold under the same brand name. At our Gangnam branch, the devices, injectables and medications used in procedures, Rejuran included, are genuine products. They aren't counterfeit versions sold under the same name. Our staff open the product packaging in front of the patient before the procedure starts, so the patient can read the product name and the printed labeling directly off the box.
Whether a product is genuine and whether it suits a given patient's skin are separate questions. Whether it has approval abroad is a separate question again. At our Gangnam branch, we check the patient's skin condition before a procedure, then select the product that fits the treatment's purpose and the area being treated.

댓글 (0)
댓글 작성
댓글을 작성하려면 로그인이 필요합니다.
로그인하기